Ocular Therapeutix Inc
(NAS:OCUL)
$
6.67
-0.02 (-0.3%)
Market Cap: 1.03 Bil
Enterprise Value: 624.63 Mil
PE Ratio: 0
PB Ratio: 2.53
GF Score: 77/100 Ocular Therapeutix Inc (OCUL) Transcripts
- Q3 2023 Ocular Therapeutix Inc Earnings Call TranscriptNov 07, 2023$2.84 (+2.90%)Earnings
- Ocular Therapeutix Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Q2 2023 Ocular Therapeutix Inc Earnings Call TranscriptAug 07, 2023$4.36 (-3.33%)Earnings
- Ocular Therapeutix Inc To Discuss the 12-Month Data TranscriptJun 12, 2023
- Ocular Therapeutix Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Ocular Therapeutix Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q1 2023 Ocular Therapeutix Inc Earnings Call TranscriptMay 08, 2023$6.4 (+2.40%)Earnings
- Q4 2022 Ocular Therapeutix Inc Earnings Call TranscriptMar 06, 2023$5.58 (-5.58%)Earnings
- Ocular Therapeutix Inc To Discuss Interim Data Update Call TranscriptFeb 13, 2023
- Q3 2022 Ocular Therapeutix Inc Earnings Call TranscriptNov 07, 2022$3.55 (+1.43%)Earnings
- Ocular Therapeutix Inc Corporate Call TranscriptSep 27, 2022
- Q2 2022 Ocular Therapeutix Inc Earnings Call TranscriptAug 08, 2022$5.06 (+2.02%)Earnings
- Q1 2022 Ocular Therapeutix Inc Earnings Call TranscriptMay 09, 2022$3.26 (-6.05%)Earnings
- Q4 2021 Ocular Therapeutix Inc Earnings Call TranscriptFeb 28, 2022$5.58 (+1.09%)Earnings
- Ocular Therapeutix Inc to Discuss Results From Its Phase 2 Clinical Trial of OTX-DED Call TranscriptDec 06, 2021
- Q3 2021 Ocular Therapeutix Inc Earnings Call TranscriptNov 08, 2021$7.1 (+1.87%)Earnings
- Q2 2021 Ocular Therapeutix Inc Earnings Call TranscriptAug 09, 2021$10.73 (+1.90%)Earnings
- Q1 2021 Ocular Therapeutix Inc Earnings Call TranscriptMay 05, 2021$16.56 (-0.96%)Earnings
- Q4 2020 Ocular Therapeutix Inc Earnings Call TranscriptMar 11, 2021$20.31 (+3.31%)Earnings
- Ocular Therapeutix Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q3 2020 Ocular Therapeutix Inc Earnings Call TranscriptNov 05, 2020$12 (-0.41%)Earnings
- Q2 2020 Ocular Therapeutix Inc Earnings Call TranscriptAug 07, 2020$8.21 (-2.96%)Earnings
- Ocular Therapeutix Inc Annual Shareholders Meeting TranscriptJun 25, 2020
- Q1 2020 Ocular Therapeutix Inc Earnings Call TranscriptMay 08, 2020$5.97 (-10.09%)Earnings
- Ocular Therapeutix Inc - Announces Results Of Phase 3 Clinical Trial of Dextenza TranscriptApr 28, 2020
- Q4 2019 Ocular Therapeutix Inc Earnings Call TranscriptMar 12, 2020$4.29 (-19.81%)Earnings
- Q3 2019 Ocular Therapeutix Inc Earnings Call TranscriptNov 12, 2019$2.57 (-12.29%)Earnings
- Q2 2019 Ocular Therapeutix Inc Earnings Call TranscriptAug 07, 2019$4.57 (-1.51%)Earnings
- Q1 2019 Ocular Therapeutix Inc Earnings Call TranscriptMay 10, 2019$3.68 (+0.55%)Earnings
- Ocular Therapeutix Inc Research & Development Day TranscriptMar 28, 2019
- Q4 2018 Ocular Therapeutix Inc Earnings Call TranscriptMar 07, 2019$4.38 (+1.86%)Earnings
- 1